Huang Cong-Xin, Liang Jin-Jun, Yang Bo, Jiang Hong, Tang Qi-Zhu, Liu Xiu-Juan, Wan Wei-Guo, Jian Xiao-Li
Department of Cardiology, Renmin Hospital of Wuhan University, Hubei, China.
Pacing Clin Electrophysiol. 2006 Apr;29(4):343-50. doi: 10.1111/j.1540-8159.2006.00351.x.
To evaluate the quality of life (QoL), health-care resource utilization, and cost for the patients with premature ventricular contractions (PVCs) by radiofrequency catheter ablation (RFCA).
RFCA was performed in 58 patients with symptomatic PVCs that were refractory/easy to medication. A 24-hour ambulatory electrocardiographic monitoring, QoL, health-care resources utilization, and cost were assessed at a screening visit and 3 and 12 months after RFCA.
RFCA was successfully performed in 56 patients (96.6%). This resulted in a significant improvement in the QoL at 3 and 12 months after the procedure. There were no major complications related to the procedure. Nine patients (15.5%) had residual arrhythmia. Seven of them underwent repeated ablation with successful results. It also improved the QoL and reduced health-care resource utilization and cost.
RFCA is a safe and effective treatment for PVCs, and it is a viable alternative to drugs in the presence of disabling symptoms.
通过射频导管消融术（RFCA）评估室性早搏（PVCs）患者的生活质量（QoL）、医疗资源利用情况及费用。
对58例症状性PVCs且药物治疗难治/易耐受的患者进行RFCA。在筛查访视时以及RFCA术后3个月和12个月评估24小时动态心电图监测、QoL、医疗资源利用情况及费用。
56例患者（96.6%）成功进行了RFCA。这导致术后3个月和12个月时QoL有显著改善。未发生与手术相关的重大并发症。9例患者（15.5%）有残余心律失常。其中7例接受了重复消融，结果成功。这也改善了QoL并减少了医疗资源利用及费用。
RFCA是治疗PVCs的一种安全有效的方法，在出现致残症状时是药物治疗的可行替代方案。
